---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-249302"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2025-10-24T23:59:59+00:00"
generated_at: "2026-05-17T02:21:33.857543+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tango Therapeutics raises ~$212M via registered direct offering and PIPE

## Summary
- Registered direct offering of 21.0M shares and 3.2M pre-funded warrants at $8.66; net proceeds ~$197M.
- Separate PIPE of 1.7M shares at $8.66 for ~$15M total gross proceeds.
- Proceeds to advance pipeline and general corporate purposes; cash runway extended into 2028.
- Closings expected October 24, 2025; customary conditions apply.
- Officers and directors to enter 60-day lock-up agreements per PIPE terms.

## SEC filing metadata
- accession: 0001193125-25-249302
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2025-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000119312525249302/0001193125-25-249302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000119312525249302/d80580d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-249302
- JSON: https://secwatch.observer/filing/0001193125-25-249302.json
- Plain text: https://secwatch.observer/filing/0001193125-25-249302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.